Načítá se...
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
BACKGROUND: Clinical trials have established the efficacy of ranibizumab for the treatment of neovascular age-related macular degeneration (AMD). In addition, bevacizumab is used off-label to treat AMD, despite the absence of similar supporting data. METHODS: In a multicenter, single-blind, noninfer...
Uloženo v:
| Médium: | Artigo |
|---|---|
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3157322/ https://ncbi.nlm.nih.gov/pubmed/21526923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1102673 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|